logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Olivier Molinier

ch le mans
H指数:36
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world efficacy and safety of amivantamab in EGFR exon-20-mutant non-small cell lung cancer in a French early-access program: Amexon 20 GFPC study

法国早期准入项目中阿曼曲单抗在EGFR外显子20突变非小细胞肺癌中的真实世界有效性与安全性：Amexon 20 GFPC研究

Lung Cancer
IF4.4
2025-09-260
PRE
Thomas Pierret; Laurent Greillier; Florian Guisier; Catherine Daniel; Renaud Descourt; Loick Galland; Olivier Molinier; Chantal Decroisette; Alexis Cortot; Diane Moreau; Laurence Bigay Gamé; Marie Wislez; Nicolas Cloarec; Hubert Curcio; Nicolas Delberghe; Jacques Cadranel; Boris Duchemann; Anne Claire Toffart; Christos Chouaïd; Jean-Bernard Auliac
MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial

MiR-193b-3p和miR-132-3p作为IFCT-0701 MAPS III期试验中接受一线贝伐珠单抗联合培美曲塞-铂类化疗的恶性胸膜间皮瘤患者的生存预后生物标志物

Translational Oncology
IF4.1
2025-09-050
PREAI
Guénaëlle Levallet; Christian Creveuil; Alexandre Léger-Vigot; Solenn Brosseau; Claire Danel; Arnaud Scherpereel; Sylvie Lantuejoul; Julien Mazières; Laurent Greillier; Clarisse Audigier-Valette; Emmanuel Bergot; Denis Moro-Sibilot; Olivier Molinier; Hervé Léna; Isabelle Monnet; Franck Morin; Valérie Gounant; Gérard Zalcman
Response to letter Re: “Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS”

回复函：关于“吗啡和二甲双胍影响非小细胞肺癌患者免疫治疗效果：IFCT-1502 CLINIVO-SNDS真实世界研究的结果”

European Journal of Cancer
IF7.1
2025-07-300
PRE
Elisa Gobbini; Alexandra Langlais; Pascale Missy; Sébastien Chanoine; Benjamin Besse; Pierre-Jean Souquet; Fabrice Barlesi; Clarisse Audigier-Valette; Anne-Cécile Métivier; Isabelle Monnet; José Hureaux; Gaelle Jeannin; Jacques Cadranel; Aurélie Lagrange; Quân Tran; Franck Morin; Olivier Molinier; Virginie Westeel; Nicolas Girard; Denis Moro-Sibilot
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS

吗啡和二甲双胍影响NSCLC患者免疫治疗效果：IFCT-1502 CLINIVO-SNDS真实世界研究的结果

European Journal of Cancer
IF7.1
2025-06-110
PRE
Elisa Gobbini; Alexandra Langlais; Pascale Missy; Sébastien Chanoine; Benjamin Besse; Pierre-Jean Souquet; Fabrice Barlesi; Clarisse Audigier-Valette; Anne-Cécile Métivier; Isabelle Monnet; José Hureaux; Gaelle Jeannin; Jacques Cadranel; Aurélie Lagrange; Quân Tran; Franck Morin; Olivier Molinier; Virginie Westeel; Nicolas Girard; Denis Moro-Sibilot
Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-10-010
PRE
Falchero, Lionel; Meyer, Nicolas; Molinier, Olivier; Al Freijat, Faraj; Pegliasco, Herve; Lecuyer, Emmanuelle; Stoven, Luc; Belmont, Laure; Loutski, Sandrine; Maincent, Cecile; Blanchet-Legens, Anne-Sophie; Mairovitz, Alexa; Meniai, Fatima; Hominal, Stephane; Letierce, Alexia; Morel, Hugues; Debieuvre, Didier
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)
TARGETED ONCOLOGY
IF4
2023-11-151
PRE
Dhamelincourt, Estelle; Descourt, Renaud; Rousseau-Bussac, Gaelle; Doubre, Helene; Decroisette, Chantal; Demontrond, Pierre; Le Garff, Gwenaelle; Falchero, Lionel; Huchot, Eric; Vieillot, Sabine; Corre, Romain; Kazulinski, Laure; Bizieux, Acya; Bigay-Game, Laurence; Morel, Hugues; Molinier, Olivier; Chouaid, Christos; Guisier, Florian
Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies

20年来肺癌趋势和肿瘤特征变化 (2000-2020): 法国连续三次全国前瞻性队列研究的结果

LANCET REGIONAL HEALTH-EUROPE
IF13
2022-11-0129
OA
Debieuvre, Didier; Molinier, Olivier; Falchero, Lionel; Locher, Chrystele; Templement-Grangerat, Dorine; Meyer, Nicolas; Morel, Hugues; Duval, Yannick; Asselain, Bernard; Letierce, Alexia; Tredaniel, Jean; Auliac, Jean-Bernard; Bylicki, Olivier; Moreau, Lionel; Fore, Mathieu; Corre, Romain; Couraud, Sebastien; Cortot, Alexis
Nivolumab (Nivo) plus ipilimumab (Ipi) 6-months treatment versus continuation in patients with advanced non-small cell lung cancer (aNSCLC): Results of the randomized IFCT-1701 phase III trial
ANNALS OF ONCOLOGY
IF65.4
2022-09-016
OAAI
Zalcman, G.; Flandin, A-C. Madroszyk; Molinier, O.; Dayen, C.; Egenod, T.; Debieuvre, D.; Beaucaire-Danel, S.; Dixmier, A.; Pichon, E.; Girodet, S. Galland; Giroux-Leprieur, E.; Cloarec, N.; Cadranel, J.; Otto, J.; Romand, P.; Langlais, A.; Morin, F.; Antoine, M.; Westeel, V.; Toffart, A. C.
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2022-03-161
OA
Maille, Elodie; Levallet, Jerome; Dubois, Fatemeh; Antoine, Martine; Danel, Claire; Creveuil, Christian; Mazieres, Julien; Margery, Jacques; Greillier, Laurent; Gounant, Valerie; Moro-Sibilot, Denis; Molinier, Olivier; Lena, Herve; Monnet, Isabelle; Bergot, Emmanuel; Langlais, Alexandra; Morin, Franck; Sherpereel, Arnaud; Zalcman, Gerard; Levallet, Guenaelle
A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non-Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation

在EGFR突变的非小细胞肺癌患者中成功使用克唑替尼治疗以克服对奥希替尼的耐药性的病例报告，该患者携带获得性MET外显子14突变

CLINICAL LUNG CANCER
IF3.3
2022-03-017
PREAI
Pinquie, Francois; Cortot, Alexis B.; Chevalier, Louise-Marie; Morel, Alain; Sandrini, Jeremy; Guguen, Camille; Morvan, Benjamin; Molinier, Olivier
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
ANNALS OF ONCOLOGY
IF65.4
2022-01-0158
OAAI
Peters, S.; Pujol, J-L; Dafni, U.; Domine, M.; Popat, S.; Reck, M.; Andrade, J.; Becker, A.; Moro-Sibilot, D.; Curioni-Fontecedro, A.; Molinier, O.; Nackaerts, K.; Molla, A. Insa; Gervais, R.; Lopez Vivanco, G.; Madelaine, J.; Mazieres, J.; Faehling, M.; Griesinger, F.; Majem, M.; Gonzalez Larriba, J. L.; Provencio Pulla, M.; Vervita, K.; Roschitzki-Voser, H.; Ruepp, B.; Mitchell, P.; Stahel, R. A.; Le Pechoux, C.; De Ruysscher, D.
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
JOURNAL OF CLINICAL MEDICINE
IF2.9
2020-11-2734
OAAI
Herbreteau, Guillaume; Langlais, Alexandra; Greillier, Laurent; Audigier-Valette, Clarisse; Uwer, Lionel; Hureaux, Jose; Moro-Sibilot, Denis; Guisier, Florian; Carmier, Delphine; Madelaine, Jeannick; Otto, Josiane; Souquet, Pierre-Jean; Gounant, Valerie; Merle, Patrick; Molinier, Olivier; Renault, Aldo; Rabeau, Audrey; Morin, Franck; Denis, Marc G.; Pujol, Jean-Louis
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial

老年晚期非小细胞肺癌患者卡铂和每周紫杉醇双重化疗后切换维持化疗与观察: IFCT-1201模型试验

EUROPEAN JOURNAL OF CANCER
IF7.1
2020-10-014
PREAI
Quoix, Elisabeth; Audigier-Valette, Clarisse; Lavole, Armelle; Molinier, Olivier; Westeel, Virginie; Barlesi, Fabrice; Le Treut, Jacques; Pichon, Eric; Dauba, Jerome; Otto, Josiane; Moreau, Lionel; Madelaine, Jeannick; Dumont, Patrick; Margery, Jacques; Debieuvre, Didier; Renault, Patrick Aldo; Pujol, Jean-Louis; Langlais, Alexandra; Morin, Franck; Moro-Sibilot, Denis; Souquet, Pierre-Jean
Durvalumab (D) compared to maintenance chemotherapy (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the randomized SAFIR02 LUNG-IMMUNO trial
ANNALS OF ONCOLOGY
IF65.4
2020-09-011
OAAI
Barlesi, F.; Karimi, M.; Tomasini, P.; Daniel, C.; Raimbourg, J.; Quoix, A-E.; Flandin, A-C. Madroszyk; Mazieres, J.; Molinier, O.; Audigier-Valette, C.; Moro-Sibilot, D.; Morel, H.; Souquet, P-J.; Bieche, I.; Tran-Dien, A.; Jacquet, A.; Adam, J.; Soria, J-C.; Besse, B.
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients
CLINICAL LUNG CANCER
IF3.3
2020-09-0146
OAAI
Gobbini, Elisa; Toffart, Anne Claire; Perol, Maurice; Assie, Jean-Baptiste; Duruisseaux, Michael; Coupez, Dahna; Dubos, Catherine; Westeel, Virginie; Delaunay, Myriam; Guisier, Florian; Veillon, Remi; Gounant, Valerie; Leprieur, Etienne Giroux; Vanel, Francois-Roger; Chaabane, Nouha; Dansin, Eric; Babey, Helene; Decroisette, Chantal; Barlesi, Fabrice; Daniel, Catherine; Fournel, Pierre; Mezquita, Laura; Oulkhouir, Youssef; Canellas, Anthony; Duchemann, Boris; Molinier, Olivier; Alcazer, Vincent; Moro-Sibilot, Denis; Levra, Matteo Giaj
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous nonesmall-cell lung cancer: Results of the IFCT-1103 ULTIMATE study
EUROPEAN JOURNAL OF CANCER
IF7.1
2020-05-0147
OAAI
Cortot, Alexis B.; Audigier-Valette, Clarisse; Molinier, Olivier; Le Moulec, Sylvestre; Barlesi, Fabrice; Zalcman, Gerard; Dumont, Patrick; Pouessel, Damien; Poulet, Claire; Fontaine-Delaruelle, Clara; Hiret, Sandrine; Dixmier, Adrien; Renault, Patrick-Aldo; Becht, Catherine; Raffy, Olivier; Dayen, Charles; Mazieres, Julien; Pichon, Eric; Langlais, Alexandra; Morin, Franck; Moro-Sibilot, Denis; Besse, Benjamin

研究方向

暂未获取到该数据
D
Denis Moro‐Sibilot
H 指数:69论文数:632被引数:3.2万
F
Franck Morin
H 指数:37论文数:347被引数:7,766
F
Fabrice Barlési
H 指数:99论文数:1,480被引数:7.1万
A
Alexandra Langlais
H 指数:21论文数:234被引数:2,588
C
Clarisse Audigier-Valette
H 指数:39论文数:314被引数:1.3万
J
Julien Mazières
H 指数:91论文数:996被引数:4.8万
É
Élisabeth Quoix
H 指数:58论文数:510被引数:1.4万
V
Virginie Westeel
H 指数:49论文数:398被引数:1.1万
D
D. Debieuvre
H 指数:0论文数:3被引数:32
G
Gérard Zalcman
H 指数:64论文数:888被引数:2.9万